Introduction of Innovative Treatment Solutions for Cancer is Accelerating the Growth for Asia-Pacific Single Use System in Bio-Pharma Market

 The Asia-Pacific Single Use System in Bio-Pharma market is projected to grow at an astronomical rate on account of burgeoning government spending towards the developments in bioprocessing equipment and introduction of innovative treatment solutions for cancer, cardiovascular & infectious diseases. Moreover, surging demand of disposables technology in biopharmaceutical industry to increase productivity, efficiency, burgeoning spending towards R&D activities for drug development coupled with escalating production of monoclonal antibodies and significantly improving life science infrastructure are some of the factors driving the growth of the market in the forecasted period.

Based on Bioprocessing, Large-scale segment acquired the majority market share in 2019. The growth of the segment is attributed to growing need for single use system is surging among the biopharmaceutical enterprise and contract manufacturing organizations to achieve better efficiency at lower cost and also for various R&D and clinical trials. 

Moreover, Small-scale segment is also projected to grow in the forthcoming years on account of increase in the number of small biotechnology start-ups and biopharmaceutical enterprises which is propelling the demand for single-use technology as it provides flexibility, reduced capital, and operating costs.

China dominated the Asia-Pacific Single Use System in Bio-Pharma market in 2019. This is due to boost in the government expenditure for the development of R&D facilities, snowballing adoption single-use technologies (SUTs) by pharmaceutical industry to help the patient to access new therapeutics and growing awareness regarding the benefits of single-use bioreactors. Apart from this, strong foothold of manufacturing single-use product, surging demand for cost effective modular bioprocessing facilities and introduction of new innovative products are some of the factors proliferating the growth of the market in the forecasted timeline.

The key players with a considerable market share in the Asia-Pacific Single Use System in Bio-Pharma market include GE Healthcare, MilliporeSigma, Entegris, Pall Corporation, Eppendorf, Corning, Thermo Fisher Scientific, Sartorius, PBS Biotech, Merck KGaA, Saint Gobain, Danaher Corp., Parker Hannifin Corp, and Kuhner, Rentschler Biopharma etc.